Not just a nursing home problem: Antipsychotic use increasing in elderly, community-dwelling dementia patientsApril 24, 2018
While regulatory focus has pushed the use of antipsychotics lower in skilled nursing facilities recently, off-label use is rising among dementia patients living in assisted living and other community settings.
Q: The United Church Homes has reduced antipsychotic medications dramatically since 2012. How did you accomplish that?
The Food and Drug Administration approved a new type of antipsychotic pill in November that is able to share information about when it was taken with patients and providers — but the new tech comes with a warning for older patients.
Federal regulators have reversed a controversial proposal that would have required facilities to hire consultant pharmacists to review residents' medications.
The Centers for Medicare & Medicaid Services is launching two new initiatives that may improve mental health services for seniors and nursing home residents.
Nursing home regulators in Massachusetts Thursday launched a campaign to limit the use of antipsychotic drugs in facilities.